Gallium-68-DOTA-N-Octreotide ( DrugBank: Octreotide )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
84. サルコイドーシス
臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2016-002160-14-NL (EUCTR) | 22/11/2016 | 25/10/2016 | Octreotide PET/CT scan for the imaging of disease activity in neurologic and cardiac sarcoidosis. | 68Ga-DOTA-NOC PET/CT for the imaging of disease activity in neurologic and cardiac sarcoidosis. - SCAN-GO Trial | Sarcoidosis.;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | Product Name: Gallium-68-DOTA-N-Octreotide Product Code: Ga-68-DOTA-NOC INN or Proposed INN: Ga-68-DOTA-NOC Other descriptive name: DOTANOC | St. Antonius Hospital | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Phase 2 | Netherlands |